-
Case Report: Diagnostic challenges in VEXAS syndrome with novel ultrastructural lung findings: IgG4-RD and vasculitis as relevant differential diagnoses
Etzel, P., Lang, D., Öberseder, G. & Lamprecht, B., 21 Jan 2026, In: Frontiers in Immunology. 16, 7 p., 1742328.Research output: Contribution to journal › Article › peer-review
Open Access -
Antifibrotic treatment for fibrosing ILD in Austria - prescription and dosing characteristics according to health insurance claims data 2019-2024
Etzel, P., Kaiser, B., Lang, D. & Lamprecht, B., Oct 2025, In: Wiener klinische Wochenschrift. 137, p. 284 1 p., P28.Research output: Contribution to journal › Meeting Abstract › peer-review
-
Clinical Characteristics and Outcomes of Super-Responders to Immune Checkpoint Inhibitor Therapy in Advanced Non-Small Cell Lung Cancer
Pirklbauer, V., Etzel, P., Hohn, M., Kaiser, B., Lamprecht, B. & Lang, D., Oct 2025, In: Wiener klinische Wochenschrift. 137, p. 289 1 p., P38.Research output: Contribution to journal › Meeting Abstract › peer-review
-
Diagnostic Challenges in VEXAS Syndrome: IgG4-RG and Vasculitis as Relevant Differential Diagnosis
Etzel, P., Habringer, A., Lamprecht, B. & Lang, D., Oct 2025, In: Wiener klinische Wochenschrift. 137, p. 296 1 p., P53.Research output: Contribution to journal › Meeting Abstract › peer-review
-
Immune-Related Adverse Events in Long-Term Responders to Immunotherapy in NSCLC: Predictors and Clinical Impact
Etzel, P., Pirklbauer, V., Hohn, M., Kaiser, B., Lamprecht, B. & Lang, D., Oct 2025, In: Wiener klinische Wochenschrift. 137, p. 297 1 p., P54.Research output: Contribution to journal › Meeting Abstract › peer-review
Activities
- 4 Poster presentation
-
Diagnostic Challenges in VEXAS Syndrome: IgG4-RD and Vasculitix as Relevant Differential Diagnoses
Etzel, P. (Speaker), Lamprecht, B. (Speaker) & Lang, D. (Speaker)
16 Oct 2025 → 18 Oct 2025Activity: Talk or presentation › Poster presentation › science-to-science
-
Antifrbrotic treatment for fibrosing ILD in Austria - prescription an dosing characteristics according to health insurance claims data 2019-2024
Etzel, P. (Speaker), Kaiser, B. (Speaker), Lang, D. (Speaker) & Lamprecht, B. (Speaker)
16 Oct 2025 → 18 Oct 2025Activity: Talk or presentation › Poster presentation › science-to-science
-
Clinical Characteristics and Outcomes of Super-Responder to Immune Checkpoint Inhibitor Therapy in Advanced Non-Small Cell Lung Cancer
Pirklbauer, V. (Speaker), Etzel, P. (Speaker), Hohn, M. (Speaker), Kaiser, B. (Speaker), Lamprecht, B. (Speaker) & Lang, D. (Speaker)
16 Oct 2025 → 18 Oct 2025Activity: Talk or presentation › Poster presentation › science-to-science
-
Immune-Related Adverse Events in Long-Term Responders to Immunotherapy in NSCLC: Predictors and Clinical Impact
Etzel, P. (Speaker), Pirklbauer, V. (Speaker), Hohn, M. (Speaker), Kaiser, B. (Speaker), Lamprecht, B. (Speaker) & Lang, D. (Speaker)
16 Oct 2025 → 18 Oct 2025Activity: Talk or presentation › Poster presentation › science-to-science